9 March 2011, through the kindness and generosity of 478 people pledging their support, the proposed “ONE MORE GIRL” documentary has reached the initial funding goal. FOR IMMEDIATE RELEASE PRLog (Press Release) – Mar 14, 2011 – Victims of adverse reactions after HPV vaccination will have a voice thanks to these contributors and […]
N.J. Assemblyman rejects parents' plea for more say on kids' vaccinations
HJ.com
Published: Tuesday, March 08, 2011, 6:10 AM Updated: Tuesday, March 08, 2011, 9:16 AM
By Matt Friedman/Statehouse Bureau
TRENTON — The impassioned debate went on for more than an hour — despite witnesses being limited to only 90 seconds per statement.
But a bill that would allow parents to claim a conscientious objection from having their children vaccinated was firmly shot down Monday by the chairman of the Assembly Health and Senior Services Committee, who called it a “recipe for disaster.”
The debate marked the first time in seven years the controversial proposal was put up for formal discussion in the Assembly, and had appeared for a time to be gaining some momentum.
NVIC's "Ask Nurse Vicky" Educates Consumers
NVIC’s “Ask Nurse Vicky March 10, 2011 NVIC’s “Ask Nurse Vicky” Educates Consumers A new online video health education program produced by the National Vaccine Information Center (NVIC) will feature Vicky Debold, RN, PhD, responding to letters from consumers asking questions about vaccination. Since its founding in 1982, NVIC has responded to letters and telephone […]
GSK makes hefty price cuts for Tykerb and Cervarix in India
scripintelligence 10 March 2011 Anju Ghangurde aghangurde@yahoo.com GlaxoSmithKline has enacted significant price cuts for its breast cancer drug Tykerb (lapatinib) and the cervical cancer vaccine Cervarix in the Indian market, as part of its efforts to broaden access to the products through a flexible pricing approach. GSK told Scrip that the price… Read More
Reportlinker Adds Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
Reportlinker Adds Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
NEW YORK, March 9, 2011 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:
Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
http://www.reportlinker.com/p0312154/Cancer-Vaccines—Pipeline-Assessment-and-Market-Forecasts-to-2017.html
Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
Summary
GlobalData, the industry analysis specialist’s new report, “Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017” is an essential source of information and analysis on the global Cancer vaccines market. The report identifies key trends shaping and driving the global Atopic dermatitis disease market. It also provides insight on the prevalent competitive landscape and the emerging players expected to bring a significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Cancer vaccines sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research, and in house analysis by GlobalData’s team of industry experts.
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 92
- Next Page »